A Comparison of Zidovudine Plus Lamivudine Versus ddI Used Alone or in Combination With Zidovudine in HIV-1 Infected Children

NCT00001066 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

740

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Lamivudine
DRUG: Zidovudine
DRUG: Didanosine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]